Fidelity SPDR Advertisement
Home > Boards > US Listed > Medical - Drugs >

RXI Pharmaceuticals Corp (RXII)

Add RXII Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator Inoviorulez
Search This Board:
Last Post: 8/20/2014 12:29:47 PM - Followers: 69 - Board type: Free - Posts Today: 8

About RXi Pharmaceuticals

RXi Pharmaceuticals Corporation (OTC: RXII) is a biotechnology company focused on discovering, developing and commercializing innovative therapies based on its proprietary, next-generation RNAi platform.  Therapeutics that use RNA interference, or "RNAi," have great promise because of their ability to "silence," or down-regulate, the expression of a specific gene that may be overexpressed in a disease condition.  Building on the pioneering work of scientific founder and Nobel Laureate Dr. Craig Mello, RXi's first RNAi product candidate, RXI-109, entered into RXi's first human clinical trial in 2012.  RXI-109 targets connective tissue growth factor (CTGF), a key regulatory of fibrosis and scar formation, and is initially being developed to reduce or inhibit scar formation in the skin following surgery.

RXi Pharmaceuticals Corp., has received patent approval for their new experimental breast cancer vaccine which became part of the company's arsenal after acquiring Apthera Inc. in April of this year.
The specific patents in question regard using the vaccine NeuVax with the drug Herceptin which is used in women to slow the production of the HER2 protein in tumors, while NeuVax attempts to make the body's immune system fight off cancerous cells.
According to The Telegram:
"The patents also cover using NeuVax in patients not eligible for Herceptin treatment."
With their patent in place the company plans to begin human tests in early 2012.
According to RXi the patents were developed by Dr. George E. Peoples, director of the Cancer Vaccine Development Program for the U.S. Military Cancer Institute and RXi is leasing the patents for their own work.

This May, RXi Pharmaceuticals Corp. observed two momentous events: The biotechnology company completed its spinoff from Galena Biopharma Inc., and Dr. Geert Cauwenbergh took the helm as president and chief executive officer. The small company's first product, an anti-scarring medication called RXI-109, entered clinical trials this year, and is based on the pioneering work in RNA interference of RXi scientific founder and Nobel Laureate Dr. Craig C. Mello. Dr. Cauwenbergh came to RXi after a long career in pharmaceuticals, most recently as president and chief executive officer of a company he founded, Barrier Therapeutics. What attracted you to come to Worcester? "It was the technology, well, the technology and the chemistry with these people. They're very bright." As a publicly traded company, how do you reconcile the needs of the investors, which are sometimes a short-term desire for profits, with the needs of medical research, which sometimes takes years? "Through business development. Basically what you do as a small biotech is you try to create a big network with people who have interest in various stages of development. ... In two or three years they get antsy and they want to cash in, but at that point in time there will be and there is already a network of business development contacts in place where you can for instance get nondiluted money without having to raise money and go back to the stock market and shareholders by making regional deals or geographic deals ...

Press Releases
RXi Pharmaceuticals to Present at Biotech Showcase™ 2013 - December 19, 2012
RXi Pharmaceuticals Announces Initiation of Second Double-Blind Vehicle Controlled Phase 1 Study With Its Anti-Scarring Compound, RXI-109 - December 5, 2012
RXi Pharmaceuticals Announces Pharmacokinetic Results of its Single Dose Phase 1 Study with RXI-109 in Healthy Volunteers - November 15, 2012
RXi Pharmaceuticals Reports Financial Results for the Third Quarter of 2012 - November 14, 2012
RXi Pharmaceuticals to Present at 12th Annual Biotech Symposium - October 16, 2012
RXi Pharmaceuticals Awarded NCI SBIR Funding to Advance Self-Delivering RNAi Technology - October 4, 2012
RXi Pharmaceuticals to Present at 11th Annual BIO Investor Forum - October 2, 2012
RXi Pharmaceuticals Announces Completion of Dosing in Phase 1 Trial for RXI-109 Program - September 24, 2012
RXi Pharmaceuticals Reports Financial Results for the Second Quarter of 2012 - August 15, 2012
RXi Pharmaceuticals Appoints Jeannette Graf MD and Leroy Young MD to its Scientific Advisory Board - July 13, 2012

Share Statistics
Avg Vol (3 month)3: 215,443
Avg Vol (10 day)3: 145,371
Shares Outstanding5: 338m
Float: 53.34M
% Held by Insiders1: 9.01%
% Held by Institutions1: 0.50%


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
RXII News: RXi Pharmaceuticals Reports Financial Results for the Second Quarter of 2014 08/14/2014 07:05:00 AM
RXII News: RXi Pharmaceuticals Celebrates Expansion of its Operations in Massachusetts 07/02/2014 07:02:00 AM
RXII News: RXi Pharmaceuticals Set to Join Russell Microcap Index 06/25/2014 07:02:00 AM
RXII News: RXi Pharmaceuticals Granted Key Patent Related to Self-Delivering Technology for the Treatment of Fibrotic Disorders 03/05/2014 07:02:00 AM
RXII News: RXi Pharmaceuticals to Present at the 24th Annual Wall Street Analyst Forum 02/24/2014 07:02:00 AM
#1438   Please. This trash stock is worth a few piperblumoone 08/20/14 12:29:47 PM
#1437   I suppose u like losing your piperblumoone 08/20/14 12:28:43 PM
#1436   More like 80 cents or 8 cents. Impending piperblumoone 08/20/14 12:27:34 PM
#1435   And I agree as well. piperblumoone 08/20/14 12:25:45 PM
#1434   I totally agree with your assessment. piperblumoone 08/20/14 12:25:21 PM
#1433   This POS stock is worthless. They have nothing piperblumoone 08/20/14 12:24:49 PM
#1432   Ceo RXII news coming to end august BULLISH sedrik 08/20/14 07:16:18 AM
#1431   RXi Pharmaceuticals Expands Clinical Program with Initiation of sedrik 08/20/14 07:15:17 AM
#1430   Couldn't agree more. Good times are not that Titan V 08/15/14 09:11:03 PM
#1429   I added more shares for Monday in RXII Inoviorulez 08/15/14 09:05:32 PM
#1428   $RXII H.C. Wainwright Reiterates Buy On RXi Pharmaceuticals maytepper 08/15/14 12:02:27 PM
#1427   RXII end of year will easy 6-9 sedrik 08/15/14 07:55:02 AM
#1426   Some big name institutional investors in June update Titan V 08/14/14 10:53:03 PM
#1425   Dr. Phillip Frost had even invested in a sedrik 08/14/14 03:57:11 AM
#1424   RXii green Europe Stock today 3% sedrik 08/13/14 08:48:47 AM
#1423   Once the phase 2 results are out wall Inoviorulez 08/07/14 05:31:48 PM
#1422   $RXII represents an undervalued player in the RNA wildbullus 08/07/14 02:25:12 PM
#1421   RXi Pharmaceuticals Expands Clinical Program with Initiation of Inoviorulez 07/30/14 07:57:56 PM
#1420   RXi Pharmaceuticals Expands Clinical Program with Initiation of sedrik 07/30/14 08:21:14 AM
#1419   July 30, 2014, 7:02 a.m. EDT sedrik 07/30/14 08:20:19 AM
#1418   I've been waiting for some liquidity. Hoping to Titan V 07/21/14 05:40:01 PM
#1417   Anyone else adding more shares? I'm about to Inoviorulez 07/21/14 05:23:40 PM
#1416   Sedrik you should join the StockTwits RXII board Titan V 07/20/14 10:58:41 AM
#1415   If CEO can buy 100k shares, that more convincing. wildbullus 07/17/14 06:17:29 PM
#1414   TODAY CEO bought another 1000 shares very good sedrik 07/17/14 10:28:20 AM
#1413   Seekingalpha.. Rxi Pharmaceuticals is only getting started and sedrik 07/17/14 06:20:04 AM
#1412   The best part about this study was the sedrik 07/17/14 05:46:32 AM
#1411   THE LIFE SCIENCES REPORT 7/11/2014 RXII sedrik 07/13/14 07:20:20 AM
#1410   Im long for RXII I have 2000 shares sedrik 07/10/14 06:54:52 AM
#1409   CEO bought another 1400 shares very good sedrik 07/10/14 06:54:05 AM
#1408   I'll pitch in with 3600 shares in the pistol1p 07/09/14 11:17:23 PM
#1407   $RXII looks like Geert bought another 1400 shares wildbullus 07/09/14 05:04:29 PM
#1406   "Why I’m Still Long Rxi Pharmaceuticals After Recent Inoviorulez 07/09/14 10:51:47 AM
#1405   Sedrik, link on the insider buying yesterday? wildbullus 07/09/14 09:48:52 AM
#1404   News insiders buying yestarday positives sedrik 07/09/14 09:34:10 AM
#1403   BILLIONS DOLLARS COMPANY sedrik 07/08/14 09:36:59 AM
#1402   DONT FORGET ON POSITIVE DATA Positive Results with sedrik 07/08/14 09:36:28 AM
#1401   RXi Pharmaceuticals Celebrates Expansion of its Operations in sedrik 07/08/14 03:39:08 AM
#1400   RXi Pharmaceuticals Appoints Peter Campochiaro M.D. to its Inoviorulez 07/07/14 04:30:59 PM
#1399   Where is the link? wildbullus 07/07/14 08:47:00 AM
#1398   Nice Titan V 07/07/14 08:03:41 AM
#1397   Analitics Rxii undervalue , shares worth 100 sedrik 07/07/14 07:58:48 AM
#1396   RXi Pharmaceuticals Appoints Peter Campochiaro M.D. to its sedrik 07/07/14 07:55:47 AM
#1395   RXi Pharmaceuticals Corp CEO Geert Cauwenbergh Buys 2,000 Shares sedrik 07/03/14 11:46:35 AM
#1394   RXi Pharmaceuticals Granted US Notice of Allowance Covering sedrik 07/03/14 11:44:06 AM
#1393   RXi Pharmaceuticals Set to Join Russell Microcap Index sedrik 07/03/14 10:44:35 AM
#1392   $RXII #UnderValued #Alert 10dMA=$2.99? 20dMA=$3.01? 50dMA=$3.10? 100dMA=$3.98 sedrik 07/03/14 10:41:59 AM
#1391   BUY ALERT FOR RXII SEEKING ALPHA sedrik 07/03/14 09:18:37 AM
#1390   CEO CAUWENBERGH GEERT bought 2000 share yestarday sedrik 07/03/14 09:06:17 AM
#1389   $RXII #UnderValued #Alert 10dMA=$2.99? 20dMA=$3.01? 50dMA=$3.10? 100dMA=$3.98? 2 sedrik 07/02/14 11:34:18 AM